TABLE 1.
Reference | Species | Disease | Intervention | irAE organ affected | Microbiota analysis method | Significant outcome | Potential mechanism |
---|---|---|---|---|---|---|---|
Chaput et al. 18 |
26 patients | Metastatic melanoma | Anti‐CTLA‐4 | Colitis | 16 s rRNA |
Baseline phyla level: enriched Firmicutes in patients with colitis, high proportions of Bacteroidetes in patients without colitis 15 bacterial OTUs were detected as potential biomarkers of colitis onset. 5/6 OTUs (e.g., B. uniformis, B. vulgatus, Parabacteroides distasonis, Prevotella) from the Bacteroidetes phylum were associated with an absence of colitis. 8/9 OTUs (e.g., Faecalibacterium prausnitzii, Gemmiger formicilis, Roseburia inulinivorans, Fusicatenibacter saccharivorans, Blautia obeum, Clostridiales bacterium, butyrate‐producing bacteria from the Firmicutes phylum) were associated with colitis. |
Low proportion of peripheral blood regulatory T cells (Tregs), α4+β7+ CD4+ T cells, and α4+β7+ CD8+ T cells in patients enriched with Faecalibacterium and other Firmicutes. Patients with irAE colitis tended to have significantly higher CD4+ T cells, IL‐6, IL‐8 and sCD25. Higher inducible T cell costimulator induction on CD4+ T cells and serum CD25 in patients who enriched with Faecalibacterium. |
Dubin et al. 23 | 34 patients | Metastatic melanoma | Anti‐CTLA‐4 | Colitis | 16 s rRNA; shotgun sequencing |
Patients with or without colitis shared many bacterial taxa belonging to the Firmicutes phylum. Patients without colitis harbored a greater proportion of the Bacteroidaceae family. Patients without colitis had a higher abundance of Bacteroidaceae, Rikenellaceae, and Barnesiellaceae from the Bacteroidetes phylum. |
Genetic pathways involved in polyamine transport and B vitamin biosynthesis were associated with an increased risk of colitis. |
Liu et al. 24 | 26 patients | Advanced lung cancer | Anti‐PD‐1 | Colitis | 16 s rRNA |
Species abundance and diversity tended to be lower in patients with diarrhea/colitis, but without a statistical difference. Firmicutes and Bacteroidetes phylum were the most abundant in patients with or without diarrhea/colitis, respectively. Probable risk factors for diarrhea/colitis: Bacteroides and Parabacteroides from the Bacteroidetes phylum, Phascolarcto bacterium from the Firmicutes phylum, and Veillonella from the Proteobacteria phylum. |
NA |
Chau et al. 20 | 13 patients | Lung cancer | Anti‐PD‐1/PD‐L1 | Rash/colitis/myositis/pneumonitis/thrombocytopenia | 16 s rRNA | Enrichment of Bifidobacterium of Actinobacteria phylum and Desulfovibrio of Proteobacteria phylum were significantly associated with lower incidence and grade of irAEs. | NA |
SaKai et al. 25 | 18 patients | Lung/stomach/kidney/ovary cancer | ICIs | Colitis | 16 s rRNA | Decreased abundance of Bacteroides species and enriched Enterobacteria in inflamed regions of irAE colitis. | Pathways associated with molecular transport systems, including fatty acids, were enriched in irAE colitis. |
McCulloch et al. 26 | 57 patients | Melanoma | Anti‐PD‐1 | Pneumonitis/colitis/hepatitis/nephritis/arthritis/throid/adrenal/dermatologic/neurologic | 16 s rRNA | Enriched for Lachnospiraceae spp. and Streptococcus spp. | NA |
Abbreviations: CTLA‐4, cytotoxic T lymphocyte antigen‐4; ICIs, immune checkpoint inhibitors; irAEs, immune‐related adverse events; NA, not applicable; OTUs, operational taxonomic units; PD‐1, programmed cell death‐1; qPCR, quantitative polymerase chain reaction; TNBS, 2,4,6‐trinitrobenzene sulfonic acid.